FRANCISCO
CASAS MALDONADO
PROFESOR ASOCIADO CIENCIAS SALUD
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (27)
2024
-
Spanish Consensus on Remission in Asthma (REMAS)
Archivos de Bronconeumologia, Vol. 60, Núm. 8, pp. 503-509
2023
-
COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
BMC Health Services Research, Vol. 23, Núm. 1
-
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
The European respiratory journal
-
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)
Respiratory Research
-
Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
International Journal of COPD, Vol. 18, pp. 1691-1700
-
Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain
Open Respiratory Archives, Vol. 5, Núm. 3
-
What's New in the 2022 Consensus for Severe Asthma in Adults
Archivos de Bronconeumologia
2022
-
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
Respiratory Research, Vol. 23, Núm. 1
-
Consensus document for severe asthma in adults. 2022 update
Open Respiratory Archives, Vol. 4, Núm. 3
-
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
ERJ Open Research, Vol. 8, Núm. 3
-
High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study
Archivos de Bronconeumologia, Vol. 58, Núm. 12, pp. 834-836
-
Monoclonal antibody treatment for severe uncontrolled asthma in Spain: analytical map
Journal of Asthma, Vol. 59, Núm. 10, pp. 1997-2007
2020
-
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
Respiratory Medicine, Vol. 170
-
Thermoplasty in the Spotlight
Archivos de Bronconeumologia, Vol. 56, Núm. 5, pp. 269-270
2019
-
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study
PharmacoEconomics - Open, Vol. 3, Núm. 3, pp. 333-342
2018
-
Alpha-1 antitrypsin deficiency: Outstanding questions and future directions
Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1
2017
-
Seasonal variability in clinical care of COPD outpatients: Results from the andalusian COPD audit
International Journal of COPD, Vol. 12, pp. 785-792
2016
-
Determinants for changing the treatment of COPD: A regression analysis from a clinical audit
International Journal of COPD, Vol. 11, Núm. 1, pp. 1171-1178
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8
-
Guideline adherence in outpatient clinics for chronic obstructive pulmonary disease: Results from a clinical audit
PLoS ONE, Vol. 11, Núm. 3